1. Home
  2. KMPR vs DMRA Comparison

KMPR vs DMRA Comparison

Compare KMPR & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kemper Corporation

KMPR

Kemper Corporation

HOLD

Current Price

$23.97

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$21.68

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KMPR
DMRA
Founded
1990
2011
Country
United States
United States
Employees
7400
7
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KMPR
DMRA
Price
$23.97
$21.68
Analyst Decision
Hold
Buy
Analyst Count
5
2
Target Price
$47.67
$43.00
AVG Volume (30 Days)
1.1M
339.5K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
3.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.35
N/A
P/E Ratio
$14.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.69
$16.50
52 Week High
$65.32
$28.76

Technical Indicators

Market Signals
Indicator
KMPR
DMRA
Relative Strength Index (RSI) 29.50 34.92
Support Level N/A $16.50
Resistance Level $32.01 $26.66
Average True Range (ATR) 1.23 1.61
MACD -0.53 -0.29
Stochastic Oscillator 15.80 26.06

Price Performance

Historical Comparison
KMPR
DMRA

About KMPR Kemper Corporation

Kemper Corp is an insurance holding company that offers complementary insurance products through its subsidiaries, including personal and commercial automobile insurance to consumers in targeted markets and industries. Kemper also offers life and other insurance solutions based on the needs of its clients. The company offers its insurance products through a vast network of agents and brokers, mainly under the Kemper Auto and Kemper Life brands. It has two operating segments: Specialty Property & Casualty Insurance and Life Insurance. The majority of the company's revenue is generated from the Specialty Property & Casualty Insurance segment, whose principal products are specialty personal automobile and commercial automobile insurance. Geographically, it operates only in the United States.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: